Tabula Rasa HealthCare, Inc. revised preliminary revenue guidance for the fourth quarter 2022 . Revenue from continuing operations for the fourth quarter of 2022 is expected to be between $82 $83 million, exceeding the prior guidance range of $77.5 $80.5 million.
Tabula Rasa HealthCare, Inc.
Equities
TRHC
US8733791011
Advanced Medical Equipment & Technology
1st Jan change | Capi. | |
---|---|---|
-7.16% | 28.89B | |
+40.93% | 9.26B | |
+34.47% | 4.58B | |
-33.18% | 2.53B | |
-8.48% | 1.62B | |
-27.03% | 1.26B | |
-41.51% | 1.02B | |
+5.50% | 943M | |
-41.07% | 845M |